Notably, the C1 subtype of hepatocellular carcinoma (HCC) showed the highest expression levels of RPs, followed by the C2 and C3 subtypes, while the lowest levels were observed in NAT (Figure 4E). The gene discussed is BRD2; the disease is hepatocellular carcinoma.